Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    September 2019
  1. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.
    Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002959.
    PubMed     Text format     Abstract available


  2. CANNON RM, Locke JE, Orandi BJ, Anderson DJ, et al
    Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C positive recipients in the direct acting antiviral era: time to revise the kidney donor risk index?
    Transplantation. 2019 Sep 9. doi: 10.1097/TP.0000000000002949.
    PubMed     Text format     Abstract available


  3. HUANG E
    Hepatitis C Infection in Kidney Donors: A Call to Re-examine its Relevance as a Predictor of Transplant Outcomes.
    Transplantation. 2019 Sep 3. doi: 10.1097/TP.0000000000002950.
    PubMed     Text format    


    May 2019
  4. OWADA Y, Oshiro Y, Inagaki Y, Harada H, et al
    A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002801.
    PubMed     Text format     Abstract available


    March 2019
  5. DI GIORGIO A, Nicastro E, Dalla Rosa D, Nebbia G, et al
    Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood.
    Transplantation. 2019;103:544-551.
    PubMed     Text format     Abstract available


    October 2018
  6. CHARLTON MR, Gane EJ, Shukla A, Dashtseren B, et al
    International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting - From Noncirrhotic to Decompensated Disease and Following Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002453.
    PubMed     Text format     Abstract available



  7. Successful Treatment of Chronic Hepatitis C Virus Infection with Sofosbuvir and Ledipasvir in Renal Transplant Recipients: Erratum.
    Transplantation. 2018;102:e458.
    PubMed     Text format    


    July 2018
  8. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed     Text format    


  9. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Text format     Abstract available


  10. GONZALEZ-DIEGUEZ ML, Vidal DV, Mendoza Pacas GE, Houghton RF, et al
    TACROLIMUS INDUCED CHOLESTATIC HEPATITIS IN A PATIENT WITH LIVER TRANSPLANT.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002332.
    PubMed     Text format    


  11. SAGESHIMA J, Troppmann C, McVicar JP, Santhanakrishnan C, et al
    Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
    Transplantation. 2018;102:1179-1187.
    PubMed     Text format     Abstract available


  12. ANKCORN MJ, Ijaz S, Poh J, Elsharkawy AM, et al
    Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.
    Transplantation. 2018;102:1139-1147.
    PubMed     Text format     Abstract available


    June 2018
  13. BOWRING MG, Kucirka LM, Massie AB, Ishaque T, et al
    Changes in utilization and discard of HCV-antibody positive deceased-donor kidneys in the era of direct-acting antiviral therapy.
    Transplantation. 2018 Jun 13. doi: 10.1097/TP.0000000000002323.
    PubMed     Text format     Abstract available


    May 2018
  14. TUCCI A, Rizza S, Cocchis D, Martini S, et al
    Early and late hepatitis B reactivation following IFN- or DAA-based therapy of recurrent hepatitis C in anti-HBc-positive liver transplant recipients.
    Transplantation. 2018 May 2. doi: 10.1097/TP.0000000000002241.
    PubMed     Text format    


    April 2018
  15. JEON JW, Kim SM, Cho H, Baek CH, et al
    Presence of hepatitis B surface antibody in addition to hepatitis B core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen-negative patients undergoing kidney transplantation.
    Transplantation. 2018 Apr 5. doi: 10.1097/TP.0000000000002173.
    PubMed     Text format     Abstract available


    March 2018
  16. MALLET V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, et al
    Transmission of hepatitis E virus with plasma exchange in kidney-transplant recipients: a retrospective cohort study.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002185.
    PubMed     Text format     Abstract available


  17. WEDEMEYER H
    E-xchange: Hepatitis E and the risk of plasma products for organ transplant recipients.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002186.
    PubMed     Text format    


    February 2018
  18. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    PubMed     Text format    


  19. FARIA LC, Terrabuio DRB, Leblebicioglu H, Huprikar S, et al
    Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors.
    Transplantation. 2018;102.
    PubMed     Text format    


  20. DI MAIRA T, Torregrosa A, Navarro V, Sanchez D, et al
    Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment.
    Transplantation. 2018;102:e74-e81.
    PubMed     Text format     Abstract available


    January 2018
  21. MCCAULEY M, Mussell A, Goldberg D, Sawinski D, et al
    Race, Risk, and Willingness of End-stage Renal Disease Patients Without Hepatitis C (HCV) to Accept an HCV-infected Kidney Transplant.
    Transplantation. 2018 Jan 18. doi: 10.1097/TP.0000000000002099.
    PubMed     Text format     Abstract available


  22. LIM MA, Kamili S, Cohen J, Green-Montfort T, et al
    Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-center Study.
    Transplantation. 2018 Jan 11. doi: 10.1097/TP.0000000000002071.
    PubMed     Text format    


    December 2017
  23. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Text format     Abstract available


    November 2017
  24. TROTTER PB, Summers DM, Ushiro-Lumb I, Robb M, et al
    Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002033.
    PubMed     Text format     Abstract available


  25. AGARWAL N, Davis RJ, Gracey DM, Wong G, et al
    Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002034.
    PubMed     Text format    


  26. HOLSCHER CM, Durand CM, Desai NM
    Expanding the Use of Organs from Hepatitis C-Viremic Donors: The Evidence Continues to Build.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002032.
    PubMed     Text format    


  27. KAMAR N, Del Bello A, Izopet J
    Should persistent hepatitis E virus replication in transplant patients be tolerated?
    Transplantation. 2017 Nov 10. doi: 10.1097/TP.0000000000001994.
    PubMed     Text format    


    October 2017
  28. HEO NY, Mannalithara A, Kim D, Udompap P, et al
    Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.
    Transplantation. 2017 Oct 3. doi: 10.1097/TP.0000000000001953.
    PubMed     Text format     Abstract available


    September 2017
  29. RADHAKRISHNAN K, Chi A, Quan DJ, Roberts JP, et al
    Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Transplantation. 2017;101:2079-2082.
    PubMed     Text format     Abstract available


    August 2017
  30. ANTONINI TM, Coilly A, Rossignol E, Fougerou-Leurent C, et al
    Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928.
    PubMed     Text format     Abstract available


  31. CHOLANKERIL G, Li AA, Yoo ER, Ahmed A, et al
    Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001926.
    PubMed     Text format    


  32. GARCIA CR, Acosta LF, Mei X, Berger J, et al
    Liver Transplantation for the Treatment of Complicated Iatrogenic Biliary Injuries: A National Review from the UNOS Dataset.
    Transplantation. 2017 Aug 22. doi: 10.1097/TP.0000000000001922.
    PubMed     Text format     Abstract available


  33. ABAALKHAIL F, Elsiesy H, Elbeshbeshy H, Shawkat M, et al
    Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001907.
    PubMed     Text format     Abstract available


  34. MCPHERSON S, Elsharkawy AM, Ankcorn M, Ijaz S, et al
    Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001908.
    PubMed     Text format     Abstract available


    July 2017
  35. FUNG J, Wong T, Chok K, Chan A, et al
    Oral nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B with Preexisting rt204 Mutation.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001883.
    PubMed     Text format     Abstract available


  36. WALLER KMJ, Wyburn KR, Shackel NA, O'Leary MJ, et al
    Hepatitis transmission risk in kidney transplantation (the HINT study): a cross-sectional survey of transplant clinicians in Australian and New Zealand.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001885.
    PubMed     Text format     Abstract available


  37. PRUETT TL, Clark MA, Taranto SE
    Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Transplantation. 2017;101:1670-1678.
    PubMed     Text format     Abstract available


  38. VOLK ML, Wilk AR, Wolfe C, Kaul DR, et al
    The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Transplantation. 2017;101:1666-1669.
    PubMed     Text format     Abstract available


    June 2017
  39. MASUTANI K, Omoto K, Okumi M, Okabe Y, et al
    Incidence of Hepatitis B Viral Reactivation After Kidney Transplantation With Low-dose Rituximab Administration.
    Transplantation. 2017 Jun 29. doi: 10.1097/TP.0000000000001870.
    PubMed     Text format     Abstract available


    May 2017

  40. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study: Erratum.
    Transplantation. 2017;101:e193.
    PubMed     Text format    


  41. SINGH N, Dies D, Samant H
    Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Transplantation. 2017;101:e192.
    PubMed     Text format    


  42. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed     Text format    


  43. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed     Text format    


  44. TAPPER EB, Afdhal NH, Curry MP
    Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
    Transplantation. 2017;101:933-937.
    PubMed     Text format     Abstract available


    April 2017
  45. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Text format     Abstract available


  46. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    PubMed     Text format     Abstract available


    February 2017
  47. SANTOS AH JR, Casey MJ, Xuerong W, Womer KL, et al
    Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Transplantation. 2017;101:377-386.
    PubMed     Text format     Abstract available


    January 2017
  48. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


    December 2016
  49. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Text format     Abstract available


    November 2016
  50. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available


    April 2016
  51. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    March 2016
  52. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: